source
- HMNC Brain Health raises $50M Series B to advance two depression drugsHMNC Brain Health announced it has closed a $50 million Series B financing round. The capital will be used to move two depression drug candidates into mid-stage clinical trials. The round was led…
- Lilly showcases Jaypirca combination data in CLL at EHA26, debuting results from Ajax acquisitionEli Lilly highlighted new blood‑cancer data at the European Hematology Association meeting in Stockholm. The company presented early clinical results for its Jaypirca therapy combined with the stan…